ER121 (SGI-078) is an orally active non-toxic small molecule ErbB2 kinase inhibitor. ER121 shows potent antitumor activity can be used for the research of HER2-related breast cancer [1].
References:
[1]. Goel PN, et al. Targeting erbB Pathways in Breast Cancer: Dual Kinase Inhibition for Brain Metastasis and Prevention of p185HER2/Neu Tumor Development. Breast Cancer (Dove Med Press). 2024 Oct 30;16:725-733.
References:
[1]. Goel PN, et al. Targeting erbB Pathways in Breast Cancer: Dual Kinase Inhibition for Brain Metastasis and Prevention of p185HER2/Neu Tumor Development. Breast Cancer (Dove Med Press). 2024 Oct 30;16:725-733.
















